Biological properties of HIV-1 subtype B' isolates from infected Chinese blood donors at different disease stages

Virology

Volumn 384, Issue 1, 2009, Pages 161-168

  Chen, Yue ^a   Shen, Chengli ^a,b   Wu, Hao ^b   Caruso, Lori ^a   Ratner, Deena ^a   Rodriguez, Milka ^a   Chen, Xinyue ^b   Gupta, Phalguni ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Chinese HIV 1 isolates; HIV 1 biological properties; Infected blood donors

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS PATIENT; AMINO ACID SEQUENCE; ARTICLE; BLOOD DONOR; CD4 LYMPHOCYTE COUNT; CHINESE; CLINICAL ARTICLE; CYTOPATHOGENIC EFFECT; DNA SYNTHESIS; GENETIC TRAIT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROVIRUS; SYNCYTIUM; TARGET CELL; VIRUS ATTENUATION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

BLOOD DONORS; CHINA; CLONING, MOLECULAR; DISEASE PROGRESSION; DNA REPLICATION; DNA, VIRAL; FLOW CYTOMETRY; GENES, REPORTER; HIV INFECTIONS; HIV-1; HUMANS; KINETICS; PHENOTYPE; PREVALENCE; SURVIVORS; VIRAL ENVELOPE PROTEINS; VIRAL LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 58549085180     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.10.050     Document Type: Article

References (39)

1. Baba M., Nishimura O., Kanzaki N., Okamoto M., Sawada H., Iizawa Y., Shiraishi M., Aramaki Y., Okonogi K., Ogawa Y., Meguro K., and Fujino M. A small molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl. Acad. Sci. U. S. A. 96 10 (1999) 5698-5703
2. Balachandran R., Thampatty P., Rinaldo C., and Gupta P. Use of cryopreserved normal peripheral blood lymphocytes for isolation of human immunodeficiency virus from seropositive men. J. Clin. Microbiol. 26 3 (1988) 595-597
3. Balachandran R., Thampatty P., Enrico A., Rinaldo C., and Gupta P. Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties. Virology 180 1 (1991) 229-238
4. Bridger G.J., Skerlj R.T., Thornton D., Padmanabhan S., Martellucci S.A., Henson G.W., Abrams M.J., Yamamoto N., De Vreese K., Pauwels R., et al. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bistetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker. J. Med. Chem. 38 2 (1995) 366-378
5. Briggs D.R., Tuttle D.L., Sleasman J.W., and Goodenow M.M. Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages). Aids 14 18 (2000) 2937-2939
6. Cheng H., Qian X., Cao G.H., Chen C.K., Gao Y.N., and Jiang Q.W. [Study on the seropositive prevalence of human immunodeficiency virus in village residents living in a rural region of central China]. Zhonghua Liu Xing Bing Xue Za Zhi 25 4 (2004) 317-321
7. Chen Y., Craigo J.K., Ding M., Guo Y., Shen S., Zhou Y., Wu H., and Gupta P. Characterization of the gp120 of circulating HIV type 1 in a group of infected Chinese blood/plasma donors with asymptomatic and symptomatic stages of the disease. AIDS Res. Hum. Retrovir. 22 11 (2006) 1167-1171
8. Chen Y., Caruso L., Shen C., Wu H., Zhou Y., and Gupta P. Lack of differences in HIV-1 Nef functional domains in infected Chinese blood donors at different stages of disease. AIDS Res. Hum. Retrovir. 23 9 (2007) 1150-1154
9. Clevestig P., Pramanik L., Leitner T., and Ehrnst A. CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site. J. Gen. Virol. 87 Pt. 3 (2006) 607-612
10. De Clercq E., Yamamoto N., Pauwels R., Balzarini J., Witvrouw M., De Vreese K., Debyser Z., Rosenwirth B., Peichl P., Datema R., et al. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob. Agents Chemother. 38 4 (1994) 668-674
11. Fenyo E.M., Morfeldt-Manson L., Chiodi F., Lind B., von Gegerfelt A., Albert J., Olausson E., and Asjo B. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62 11 (1988) 4414-4419
12. Fenyo E.M., Albert J., and Asjo B. Replicative capacity, cytopathic effect and cell tropism of HIV. Aids 3 Suppl. 1 (1989) S5-12
13. Fouchier R.A., Groenink M., Kootstra N.A., Tersmette M., Huisman H.G., Miedema F., and Schuitemaker H. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66 5 (1992) 3183-3187
14. He N., and Detels R. The HIV epidemic in China: history, response, and challenge. Cell Res. 15 11-12 (2005) 825-832
15. Hendrix C.W., Flexner C., MacFarland R.T., Giandomenico C., Fuchs E.J., Redpath E., Bridger G., and Henson G.W. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. Agents Chemother. 44 6 (2000) 1667-1673
16. Koot M., Keet I.P., Vos A.H., de Goede R.E., Roos M.T., Coutinho R.A., Miedema F., Schellekens P.T., and Tersmette M. Prognostic value of HIV-1 syncytium inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann. Intern. Med. 118 9 (1993) 681-688
17. Lawn R.M., Efstratiadis A., O'Connell C., and Maniatis T. The nucleotide sequence of the human beta-globin gene. Cell 21 3 (1980) 647-651
18. Liu L., Su B., Zhuang K., Tien P., Chen Z., and Zhang L. Genetic characterization of full-length HIV type 1 genomes from 3 infected paid blood donors in Henan, China. J. Acquir. Immune Defic. Syndr. 40 4 (2005) 501-503
19. Matala E., Hahn T., Yedavalli V.R., and Ahmad N. Biological characterization of HIV type 1 envelope V3 regions from mothers and infants associated with perinatal transmission. AIDS Res. Hum. Retrovir. 17 18 (2001) 1725-1735
20. Michael N.L., Chang G., Ehrenberg P.K., Vahey M.T., and Redfield R.R. HIV-1 proviral genotypes from the peripheral blood mononuclear cells of an infected patient are differentially represented in expressed sequences. J. Acquir. Immune Defic. Syndr. 6 10 (1993) 1073-1085
21. Morner A., Bjorndal A., Albert J., Kewalramani V.N., Littman D.R., Inoue R., Thorstensson R., Fenyo E.M., and Bjorling E. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J. Virol. 73 3 (1999) 2343-2349
22. O'Marro S.D., Armstrong J.A., Asuncion C., Gueverra L., and Ho M. The effect of combinations of ampligen and zidovudine or dideoxyinosine against human immunodeficiency viruses in vitro. Antiviral. Res. 17 2 (1992) 169-177
23. Polzer S., Dittmar M.T., Schmitz H., and Schreiber M. The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Virology 304 1 (2002) 70-80
24. Portsmouth S., Stebbing J., Keyi X., Jianping Z., and Guohua P. HIV and AIDS in the People's Republic of China: a collaborative review. Int. J. STD AIDS 14 11 (2003) 757-761
25. Rodriguez M.A., Chen Y., Craigo J.K., Chatterjee R., Ratner D., Tatsumi M., Roy P., Neogi D., and Gupta P. Construction and characterization of an infectious molecular clone of HIV-1 subtype A of Indian origin. Virology 345 2 (2006) 328-336
26. Saksena N.K., Wang B., Steain M., Yang R.G., and Zhang L.Q. Snapshot of HIV pathogenesis in China. Cell Res. 15 11-12 (2005) 953-961
27. Schwartz S., Felber B.K., Fenyo E.M., and Pavlakis G.N. Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines. Proc. Natl. Acad. Sci. U. S. A. 86 18 (1989) 7200-7203
28. Shankarappa R., Gupta P., Learn Jr. G.H., Rodrigo A.G., Rinaldo Jr. C.R., Gorry M.C., Mullins J.I., Nara P.L., and Ehrlich G.D. Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology 241 2 (1998) 251-259
29. Shankarappa R., Margolick J.B., Gange S.J., Rodrigo A.G., Upchurch D., Farzadegan H., Gupta P., Rinaldo C.R., Learn G.H., He X., Huang X.L., and Mullins J.I. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73 12 (1999) 10489-10502
30. Su B., Liu L., Wang F., Gui X., Zhao M., Tien P., Zhang L., and Chen Z. HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. Aids 17 17 (2003) 2515-2520
31. Sundaravaradan V., Das S.R., Ramakrishnan R., Sehgal S., Gopalan S., Ahmad N., and Jameel S. Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte derived macrophages. Virol. J. 4 (2007) 126
32. Tan J.X., Kang X.J., Zhang W., Liu P.P., Tong X., and Yang R.G. Full-length clone and characterization of a human immunodeficiency virus type 1 subtype B' isolated from Hubei Province, China. Chin. Med. J. (Engl.) 120 9 (2007) 831-833
33. Tebit D.M., Nankya I., Arts E.J., and Gao Y. HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle?. AIDS Rev. 9 2 (2007) 75-87
34. Tersmette M., Gruters R.A., de Wolf F., de Goede R.E., Lange J.M., Schellekens P.T., Goudsmit J., Huisman H.G., and Miedema F. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63 5 (1989) 2118-2125
35. Wang L., Zheng X., Qian H., Lu F., and Xing H. Epidemiological study on humanimmunodeficiency virus infection among children in a former paid plasma donating community in China. Chin. Med. J. 118 (2005) 720-724
36. Wu Z., Rou K., and Detels R. Prevalence of HIV infection among former commercial plasma donors in rural eastern China. Health Policy Plan 16 1 (2001) 41-46
37. Zack J.A., Arrigo S.J., Weitsman S.R., Go A.S., Haislip A., and Chen I.S. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61 2 (1990) 213-222
38. Zhang L., Chen Z., Cao Y., Yu J., Li G., Yu W., Yin N., Mei S., Li L., Balfe P., He T., Ba L., Zhang F., Lin H.H., Yuen M.F., Lai C.L., and Ho D.D. Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china. J. Virol. 78 24 (2004) 13591-13599
39. Zhang W., Hu D., Xi Y., Zhang M., and Duan G. Spread of HIV in one village in central China with a high prevalence rate of blood-borne AIDS. Int. J. Infect. Dis. 10 6 (2006) 475-480